Skyrizi Commercial 2025. Abbvie inc on tuesday raised its 2025 sales forecast of its newer immunology drugs skyrizi and rinvoq to more than $17.5 billion as it hopes to replace the loss of revenue. In this compelling television commercial, we introduce you to skyrizi, the breakthrough medication that empowers.

Sign up to track 21 nationally aired tv ad campaigns for skyrizi (psoriasis). In the past 30 days, skyrizi (psoriasis) has had 3,565 airings and earned an airing rank of #286 with a spend ranking of #76 as compared to all other advertisers.